Drug
Yinfenidone clinical trials
Also written HEC585.
- studies test it
- 6
- open now
- 1
- in phase 3
- 1
- first study started
- 2017
Keep track of what changes. Save the yinfenidone studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
6 studies that test it; most in 2021 (3)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 1
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses yinfenidone is read from its arms, and is right about nine times in ten.
Testing it · 6
- Confirmatory Clinical Study of HEC585 Tablets in Patients With IPFRecruitingPhase 3Sunshine Lake Pharma Co., Ltd.NCT07082842Written as HEC585
- Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy SubjectsCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT07588646Written as HEC585
- Phase ll Study of HEC585 in Patients With IPFActive, not recruitingPhase 2Sunshine Lake Pharma Co., Ltd.NCT05060822Written as HEC585
- To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy VolunteersCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT05383131Written as HEC585
- Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female SubjectsCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT04512170Written as HEC585
- The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female SubjectsCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT03092102Written as HEC585